| ISHARES NASDAQ US BIOTECHNOLOGY UCITS ETF USD (ACC) | BIOTECNOLOGÍA | 48,82% | 33,18% | 30,95% | · |
| TEMPLETON GLOBAL INCOME W (ACC) EUR | MIXTO FLEXIBLE | 30,30% | 37,88% | 30,95% | · |
| BANKINTER PLATEA AGRESIVO, FI R | RVI GLOBAL | 22,45% | 34,64% | 30,94% | · |
| GOLDMAN SACHS EMERGING MARKETS EQUITY INCOME P CAP USD | RVI EMERGENTES | 49,41% | 67,33% | 30,94% | 109,74% |
| UBS (LUX) SECURITY EQUITY (EUR) P-DIST | OTROS SECTORES | 8,57% | 25,85% | 30,94% | · |
| BGF EUROPEAN EQUITY INCOME A6 SGD (HEDGED) | RVI EUROPA | 16,11% | 18,27% | 30,93% | 43,53% |
| BLACKROCK EUROPEAN UNCONSTRAINED EQUITY D2PF EUR | RVI EUROPA | 10,68% | 14,24% | 30,93% | · |
| AB SICAV I-EUROZONE GROWTH PORTFOLIO S1X EUR | RV EURO | 21,62% | 24,70% | 30,92% | 105,67% |
| BGF JAPAN FLEXIBLE EQUITY C2 USD | RVI JAPÓN | 29,81% | 50,62% | 30,92% | 107,62% |
| GOLDMAN SACHS MULTI-MANAGER EMERGING MARKETS EQUITY PORTFOLIO I CAP USD | RVI EMERGENTES | 46,84% | 62,16% | 30,91% | 127,09% |
| MAPFRE AM - GOOD GOVERNANCE FUND R EUR CAP | RVI GLOBAL | 42,16% | 34,39% | 30,91% | · |
| CHALLENGE EUROPEAN EQUITY L-A | RVI EUROPA | 22,08% | 26,50% | 30,90% | 51,33% |
| ANNUALCYCLES STRATEGIES, FI C | MIXTO FLEXIBLE | 17,76% | 28,47% | 30,89% | 80,25% |
| CAPITAL GROUP NEW WORLD FUND (LUX) Z USD | RVI EMERGENTES | 37,65% | 45,31% | 30,89% | · |
| SCHRODER ISF SWISS EQUITY A ACC USD (HEDGED) | RVI EUROPA | 12,65% | 18,99% | 30,89% | 125,15% |
| UBS (LUX) EQUITY SICAV - LONG TERM THEMES (USD) (EUR PORTFOLIO HEDGED) F-ACC | RVI GLOBAL | 38,27% | 40,51% | 30,89% | · |
| VANGUARD EMERGING MARKETS STOCK INDEX INSTITUTIONAL PLUS CHF CAP | RVI EMERGENTES | 46,06% | 56,14% | 30,89% | · |
| FRANKLIN BIOTECHNOLOGY DISCOVERY A (ACC) EUR-H1 | BIOTECNOLOGÍA | 86,94% | 77,26% | 30,88% | · |
| LORETO PREMIUM RENTA VARIABLE MIXTA, FI I | MIXTO AGRESIVO EURO | 24,71% | 32,20% | 30,88% | · |
| SCHRODER ISF ALTERNATIVE SECURITISED INCOME C ACC USD | GESTIÓN ALTERNATIVA | -0,20% | 16,05% | 30,88% | · |
